Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker

Abstract Background Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD). Methods T2*-weighted MRI was performed in 16 AD patients and 15 control subjects. All magnetic resonance images were scored qualitatively by visual assessment, and quantitatively by measuring phase shifts in the cortical gray matter and hippocampus. Statistical analysis was performed to assess differences between groups. Results Patients with AD demonstrated an increased phase shift in the cortex in the temporoparietal, frontal, and parietal regions ( P < .005), and this was associated with individual Mini-Mental State Examination scores ( r = −0.54, P < .05). Conclusion Increased cortical phase shift in AD patients demonstrated on 7-tesla T2*-weighted MRI is a potential new biomarker for AD, which may reflect amyloid pathology in the early stages.